121
Participants
Start Date
February 6, 2018
Primary Completion Date
April 10, 2019
Study Completion Date
April 6, 2022
BCX7353 capsules
BCX7353 oral capsules administered once daily
Placebo oral capsule
Matching oral capsules administered once daily
Study Center, Skopje
Study Center, Vienna
Study Center, New York
Study Center, Berlin
Study Center, Hershey
Study center, Chevy Chase
Study Center, Durham
Study Center, Madrid
Study Site, Charlotte
Study Center, Pilsen
Study Center, Tampa
Study center, Birmingham
Study Center, Grenoble
Study Center, Seville
Study center, Columbus
Study Center, Cincinnati
Study Center, Ann Arbor
Study center, Plymouth
Study Center, St Louis
Study center, Little Rock
Study Center, Paris
Study center, Dallas
Study Center, San Antonio
Study center, Austin
Study center, Colorado Springs
Study center, Scottsdale
Study center, Santa Monica
Study Center, San Diego
Study Center, Walnut Creek
Study center, Clackamas
Study Center, Spokane
Study Center, Sângeorgiu de Mureș
Study Center, Boston
Study center, Belleville
Study Center, Fair Lawn
Study center, Piscataway
Study Center, Ottawa
Study Center, Toronto
Study Center, Québec
Study Center, Brno
Study Center, Frankfurt
Study Center, Budapest
Study Center, Barcelona
Study Center, Cambridge
Study Center, Frimley
Study Center, London
Study Center, Plymouth
Lead Sponsor
BioCryst Pharmaceuticals
INDUSTRY